SYNCOMF FOR 3-6 MONTHS

For 3-6 Months

Fundamentally,
> Revenue Growth over 60% Quarterly
> Net Income Growth over 70% Quarterly
> EPS over 40% Yearly

Technically,
> Trading at the point of historically tested demand zone.
> Rising relative strength.
> Market Profile also suggesting an upmove.
> Current levels suggests buyer's entry with volumes.

Risk to Reward is 1:2.5 or more

Profit Targets: 22-28, Can book some profits at first target and then trail SL further.

Stop Loss: Below the current support, 19
Fundamental AnalysisTechnical IndicatorsniftypharmapharmasectorpharmastockssyncomformulationsTrend Analysis

Anche su:

Declinazione di responsabilità